ProfileGDS5822 / ILMN_1254853
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 53% 47% 20% 56% 57% 63% 26% 32% 40% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 123.653
GSM1276600PDAC Late Ablation Control 222.647
GSM1276601PDAC Late Ablation Control 36.720
GSM1276602PDAC Late Ablation 122.856
GSM1276603PDAC Late Ablation 228.157
GSM1276604PDAC Late Ablation 337.763
GSM1303940PDAC Late Ablation_anti-CTLA4 114.526
GSM1303941PDAC Late Ablation_anti-CTLA4 215.632
GSM1303942PDAC Late Ablation_anti-CTLA4 319.440